Stockreport

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF treatment-emergent SAEs as of 35-week assessment, with sustained improvement across key efficacy measures at decreased steroid levels and new improvement in RSBQ at mont [Read more]